The mRNA metabolism passively shapes the levels of an mRNA modification called m6A within a steady-state cell and upon stress.

NUCLEUS information resources The IAEA's NUCLEUS information resource portal provides access to over 100 scientific, technical and regulatory resources, including databases, applications, publications ...

Explore the innovative applications of mRNA technologies beyond COVID-19 vaccines. Learn about the potential and future developments in this groundbreaking field.

Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...

Discover the bioanalytical strategies crucial for unlocking the potential of LNP-mRNA vaccines. Explore the impact of these strategies on the development and efficacy of mRNA vaccines.

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing.

Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...

Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by ...

Nucleus articles from across Nature Portfolio The nucleus is the double membrane limited structure within an eukaryotic cell that contains the chromosomes, and where the DNA is replicated or ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

BioNTech is buying fellow German mRNA vaccine developer CureVac in all-stock transaction that values the acquired biotech at $1.25 billion.